Botanix Pharmaceuticals Ltd (ASX: BOT) is a clinical-stage dermatology company headquartered in the United States. The company focuses on commercialising novel, prescription-based treatments for skin conditions. Its lead product, Sofdra™, is the first FDA-approved topical gel specifically developed for primary axillary hyperhidrosis—a condition involving excessive underarm sweating. Botanix operates a lean commercial model combining traditional […]